SLC2A2 and diabetes mellitus: STZ (streptozotocin) induces diabetes in rats via the preferential accumulation of the chemical in β-cells following entry through the GLUT2 (glucose transporter) receptor (chemical structural similarly with glucose), which allows STZ to bind to this receptor.